Temporal expression of P2X7 purinergic receptor during the course of experimental autoimmune encephalomyelitis

Neurochemistry International

Volumn 57, Issue 7, 2010, Pages 823-829

  Grygorowicz, Tomasz ^a   Struzyńska, Lidia ^a   Sulkowski, Grzegorz ^a   Chalimoniuk, Małgorzata ^a   Sulejczak, Dorota ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

ATP; EAE; MS; Neurodegeneration; Neuroinflammation; Purines

Indexed keywords

MESSENGER RNA; PURINERGIC P2X7 RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TEMPORAL CORTEX; ANIMAL; BIOSYNTHESIS; CELL COMMUNICATION; COMPARATIVE STUDY; GLIA; LEWIS RAT; METABOLISM; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SIGNAL TRANSDUCTION; TIME;

ANIMALIA;

ANIMALS; CELL COMMUNICATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; NEUROGLIA; NEURONS; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; RECEPTOR CROSS-TALK; RECEPTORS, PURINERGIC P2X7; TIME FACTORS;

EID: 77958082667     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.08.021     Document Type: Article

References (49)

1. Abbracchio M.P., Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors?. Pharmacol. Ther. 1994, 64:445-475.
2. Adinolfi E., Pizzirani C., Idzko M., Panther E., Norgauer J., Di Virgilio F., Ferrari D. P2X7 receptor: death or life?. Purin. Signal. 2005, 1:219-227.
3. Anderson C.M., Nedergaard M. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci. 2006, 29:257-262.
4. Ayers M.M., Hazelwood L.J., Catmull D.V., Wang D., McKormack Q., Bernard C., Orian J.M. Early glial responses in murine models of multiple sclerosis. Neurochem. Int. 2004, 45:409-419.
5. Booth R.F., Clark J.B. A rapid method for the preparation of relatively pure, metabolically competent synaptosomes from rat brain. Biochem. J. 1978, 176:365-370.
6. -/- mice: evidence for loss of apoptotic activity in lymphocytes. J. Immunol. 2006, 170:3115-3126.
7. Chomczyński P., Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
8. Daniels K.K., Vickroy T.W. Simultaneous isolation of glial and neuronal fractions from rat brain homogenates: comparison of high-affinity l-glutamate transport properties. Neurochem. Res. 1998, 23:103-113.
9. Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 1995, 16:524-528.
10. Di Virgillio F., Chiozzi P., Falzoni S., Ferrari D., Sanz J.M., Venketaraman V., Baricordi O.R. Cytolytic P2X purinoceptors. Cell Death Differ. 1998, 5:191-199.
11. Duan S., Anderson C.M., Keung E.C., Chen Y., Chen Y., Swanson R.A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 2003, 23:1320-1328.
12. Duan S., Neary J.T. P2X(7) receptors: properties and relevance to CNS function. Glia 2006, 54:738-746.
13. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Collo G., Buell G., Di Virgillio F. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 1997, 36:1295-1301.
14. Fields R.D., Burnstock G. Purinergic signaling in neuron-glia interactions. Nat. Rev. Neurosci. 2006, 7:423-436.
15. Franke H., Krügel U., Illes P. P2 receptors and neuronal injury. Pflugers Arch.: Eur. J. Physiol. 2006, 452:622-644.
16. Gabel C.A. P2 purinergic receptor modulation of cytokine production. Purin. Signal. 2007, 3:27-38.
17. Guo L.H., Schluesener H.J. Lesional accumulation of P2X(4) receptor(+) macrophages in rat CNS during experimental autoimmune encephalomyelitis. Neuroscience 2005, 134:199-205.
18. Inoue K., Koizumi S., Tsuda M. The role of nucleotides in the neuron-glia communication responsible for brain functions. J. Neurochem. 2007, 102:1447-1458.
19. 2+-dependent plasminogen release from cultured microglia. Br. J. Pharmacol. 1998, 123:1304-1310.
20. 2+ signaling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 2002, 447:247-260.
21. John G.R., Simpson J.E., Woodroofe M.N., Lee S.C., Brosnan C.F. Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression. J. Neurosci. 2001, 21:4134-4142.
22. Kerschensteiner M., Stadelmann C., Buddeberg B.S., Merkler D., Bareyre F.M., Anthony D.C., Linington C., Bruck W., Schwab M.E. Animal model - targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am. J. Pathol. 2004, 164:1455-1469.
23. Kucher B., Neary J.T. Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-α release in lipopolysaccharide-stimulated astrocytes. J. Neurochem. 2005, 92:525-535.
24. Le Feuvre R.A., Brough D., Rothwell N.J. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur. J. Pharmacol. 2002, 447:261-269.
25. Le Feuvre R.A., Brough D., Touzani O., Rothwell N.J. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab. 2003, 23:381-384.
26. Lowry O.W., Rosenbrough N.J., Farr A.L., Randal R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
27. Marcoli M., Cervetto C., Paluzzi P., Guarnieri S., Alloisio S., Thellung S., Nobile M., Maura G. P2X7 pre-synaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release. J. Neurochem. 2008, 105:2330-2342.
28. Matute C. P2X7 receptors in oligodendrocytes: a novel target for neuroprotection. Mol. Neurobiol. 2008, 38:123-128.
29. Matute C., Torre I., Perez-Cerda F., Perez-Samartin A., Alberdi E., Etxebarria E., Arranz A.M., Ravid R., Rodrigez-Antigüedad A., Sanchez-Gomez M.V., Domercq M. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 2007, 27:9525-9533.
30. 7 receptor in the release of IL-1β in the murine brain. Brain Behav. Immun. 2008, 22:234-244.
31. Mitosek-Szewczyk K., Sulkowski G., Stelmasiak Z., Strużyńska L. Expression of glutamate transporter GLT-1 in different regions of rat brain during the course of experimental autoimmune encephalomyelitis. Neuroscience 2008, 155:45-52.
32. Morelli A., Ferrari D., Bolognesi G., Rizzuto R., Di Virgilio F. Proapoptotic plasma membrane pore: P2X7 receptor. Drug Dev. Res. 2001, 52:571-578.
33. Narcisse L., Scemes E., Zhao Y., Lee S.C., Brosnan C.F. The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 2005, 49:245-258.
34. Neary J.T., McCarthy M., Cornell-Bell A., Kang Y. Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog. Brain Res. 1999, 120:323-332.
35. Nicke A., Kuan Y.H., Masin M., Rettinger J., Marquez-Klaka B., Bender O., Górecki D.C., Murrell-Lagnado R.D., Soto F. A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J. Biol. Chem. 2009, 284:25813-25822.
36. Prineas J.W., McDonald W.I., Franklin R.J.M. Demyelinating diseases. Greenfield's Neuropathology 2002, vol. 2:471-550. Arnold, London.
37. Reinhardt R., Faber-Zuschratter H., Schneider D., Illes P. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 2004, 63:686-699.
38. Shibuya I., Tanaka K., Hattori Y., Uezono Y., Harayama N., Noguchi J., Ueta Y., Izumi F., Yamashita H. Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neuronem. J. Physiol. 1999, 514:351-367.
39. Sperlagh B., Kofalvi A., Deuchars J., Atkinson L., Miligan C.J., Buckley N.J., Vizi E.S. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus. J. Neurochem. 2002, 81:1196-1211.
40. Sperlagh B., Vizi E.S., Wirkner K., Illes P. P2X7 receptors in the nervous system. Prog. Neurobiol. 2006, 78:327-346.
41. Stover J.F., Pleines U.E., Morganti-Kossmann M.C., Kossmann T., Lowitzsch K., Kempski O.S. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur. J. Clin. Invest. 1997, 27:1038-1043.
42. Strużyńska L. The protective role of astroglia in the early period of experimental lead toxicity in the rat. Acta Neurobiol. Exp. 2000, 60:67-173.
43. Strużyńska L., Bubko I., Walski M., Rafałowska U. Astroglial reaction during the early phases of acute lead toxicity in the adult rat brain. Toxicology 2001, 165:121-131.
44. 2+ signaling. J. Neurosci. 2006, 26:1378-1385.
45. Takenouchi T., Sekiyama K., Sekigawa A., Fujita M., Waragai M., Sugama S., Iwamaru H., Hashimoto M. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch. Immunol. Ther. Exp. 2010, 58:91-96.
46. Tsumoda I., Fujinami R.S. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 1996, 55:673-686.
47. Wang X., Arcuino G., Takano T., Lin J., Peng W.G., Wan P., Li P., Xu Q., Liu Q.S., Goldman S.A., Nedergaard M. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 2004, 10:821-827.
48. Wang D., Ayers M.M., Catmull D.V., Hazelwood L.J., Bernard C.C., Orian J.M. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis. Glia 2005, 51:235-240.
49. Witting A., Chen L., Cudaback E., Straiker A., Walter L., Rickman B., Möller T., Brosnan C., Stella N. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6362-6367.